Literature DB >> 17135225

The 620W allele is the PTPN22 genetic variant conferring susceptibility to RA in a Dutch population.

J Wesoly1, X Hu, M M Thabet, M Chang, H Uh, C F Allaart, R E M Toes, J J Houwing-Duistermaat, A B Begovich, T W J Huizinga.   

Abstract

OBJECTIVES: A missense SNP, C1858T, in PTPN22 has been identified as a genetic risk factor for rheumatoid arthritis (RA). Subsequent work has suggested that other variants in this gene, in particular a haplotype marked by the minor allele of rs3789604, are associated with RA in white North Americans independent of C1858T. We tested this hypothesis in an independent white Dutch study.
METHODS: A total of 667 RA patients and 286 controls were genotyped for 13 PTPN22 single nucleotide polymorphisms (SNPs) by allele-specific kinetic polymerase chain reaction. rs3789604 was genotyped in an additional 410 RA and 270 UA patients participating in the Leiden early arthritis inception cohort. We conducted single-marker and haplotype association tests.
RESULTS: The sole haplotype strongly associated with RA in our Dutch population carries the PTPN22 1858T allele. A second haplotype identical at all other SNPs tested except 1858 was not associated with disease. No significant association of the haplotype tagged by the 3' PTPN22 SNP, rs3789604, with RA susceptibility (P = 0.134) was observed in our sample set.
CONCLUSION: We conclude that C1858T is the sole PTPN22 variant predisposing to RA in our white Dutch sample set.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17135225     DOI: 10.1093/rheumatology/kel381

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  14 in total

Review 1.  PTPN22: the archetypal non-HLA autoimmunity gene.

Authors:  Stephanie M Stanford; Nunzio Bottini
Journal:  Nat Rev Rheumatol       Date:  2014-07-08       Impact factor: 20.543

2.  Clinical characteristics and PTPN22 1858C/T variant analysis in Jordanian Arab vitiligo patients.

Authors:  Asem Alkhateeb; Firas Qarqaz; Jude Al-Sabah; Tasnim Al Rashaideh
Journal:  Mol Diagn Ther       Date:  2010-06-01       Impact factor: 4.074

3.  The PTPN22 locus and rheumatoid arthritis: no evidence for an effect on risk independent of Arg620Trp.

Authors:  Wan R Wan Taib; Deborah J Smyth; Marilyn E Merriman; Nicola Dalbeth; Peter J Gow; Andrew A Harrison; John Highton; Peter B B Jones; Lisa Stamp; Sophia Steer; John A Todd; Tony R Merriman
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

Review 4.  Tyrosine phosphatase PTPN22: multifunctional regulator of immune signaling, development, and disease.

Authors:  Nunzio Bottini; Erik J Peterson
Journal:  Annu Rev Immunol       Date:  2013-12-18       Impact factor: 28.527

Review 5.  The genetics of rheumatoid arthritis: risk and protection in different stages of the evolution of RA.

Authors:  Annie Yarwood; Tom W J Huizinga; Jane Worthington
Journal:  Rheumatology (Oxford)       Date:  2014-09-18       Impact factor: 7.580

6.  Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative.

Authors:  P Machado; I Castrejon; W Katchamart; R Koevoets; B Kuriya; M Schoels; L Silva-Fernández; K Thevissen; W Vercoutere; E Villeneuve; D Aletaha; L Carmona; R Landewé; D van der Heijde; J W J Bijlsma; V Bykerk; H Canhão; A I Catrina; P Durez; C J Edwards; M D Mjaavatten; B F Leeb; B Losada; E M Martín-Mola; P Martinez-Osuna; C Montecucco; U Müller-Ladner; M Østergaard; B Sheane; R M Xavier; J Zochling; C Bombardier
Journal:  Ann Rheum Dis       Date:  2010-08-19       Impact factor: 19.103

7.  PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis.

Authors:  Michele Ciro Totaro; Barbara Tolusso; Valerio Napolioni; Francesca Faustini; Silvia Canestri; Alice Mannocci; Elisa Gremese; Silvia Laura Bosello; Stefano Alivernini; Gianfranco Ferraccioli
Journal:  PLoS One       Date:  2011-09-16       Impact factor: 3.240

8.  Association of PTPN22 1858T/T genotype with type 1 diabetes, Graves' disease but not with rheumatoid arthritis in Russian population.

Authors:  Daria Zhebrun; Yulia Kudryashova; Alina Babenko; Alexei Maslyansky; Natalya Kunitskaya; Daria Popcova; Alexandra Klushina; Elena Grineva; Anna Kostareva; Evgeny Shlyakhto
Journal:  Aging (Albany NY)       Date:  2011-04       Impact factor: 5.682

9.  The PTPN22*C1858T functional polymorphism is associated with susceptibility to inflammatory polyarthritis but neither this nor other variants spanning the gene is associated with disease outcome.

Authors:  H Naseem; W Thomson; A Silman; J Worthington; D Symmons; A Barton
Journal:  Ann Rheum Dis       Date:  2007-07-31       Impact factor: 19.103

10.  Re-evaluation of putative rheumatoid arthritis susceptibility genes in the post-genome wide association study era and hypothesis of a key pathway underlying susceptibility.

Authors:  Anne Barton; Wendy Thomson; Xiayi Ke; Steve Eyre; Anne Hinks; John Bowes; Laura Gibbons; Darren Plant; Anthony G Wilson; Ioanna Marinou; Ann Morgan; Paul Emery; Sophia Steer; Lynne Hocking; David M Reid; Paul Wordsworth; Pille Harrison; Jane Worthington
Journal:  Hum Mol Genet       Date:  2008-04-22       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.